CVR 40503021Private limited company (ApS)Forskning og eksperimentel udvikling inden for naturvidenskab og teknik (721000)København ØFounded 7 May 2019
CVR holds no employment figures for this company.
Compiled by Dandex from the Central Business Register (CVR, datacvr.virk.dk), Erhvervsstyrelsen, and annual reports filed in XBRL. Values marked Dandex estimate are computed by Dandex from that data, not registered.
Dandex is Danish company data. Connect it once and ask about Azebiotics ApS, or any Danish company, from your assistant, the API or the command line. Answers come from the current record: owners and the ownership network, financials year by year, and the latest registered changes.
Set Up DandexGross profit
67.8K
DKK, annual report 2025
-63.8% on 2024
Result
+57.8K
DKK, annual report 2025
Equity
-288K
DKK, annual report 2025
MEVA HOLDING ApSCVR 36060808, 33.3% to under 50% of capital and votes, since 7 May 2019
CORIS Holding ApSCVR 41177551, 20% to under 25% of capital and votes, since 10 Mar 2020
and 4 moreMikkel Bendersince 7 May 2019
Equity was negative at 31 Dec 2025: -288K DKK. Dandex estimate, computed 4 Nov 2026.
CVR 297690285% to under 10% of capital and votessince 10 Mar 2020
CVR 3606080833.3% to under 50% of capital and votesnotified 21 Sep 2021since 7 May 2019
CVR 373281035% to under 10% of capital and votessince 10 Mar 2020
CVR 3983892310% to under 15% of capital and votessince 7 May 2019
CVR 4117755120% to under 25% of capital and votessince 10 Mar 2020
CVR 4117763220% to under 25% of capital and votessince 10 Mar 2020
Holders of 5% or more, from the owner register. CVR records shares in bands, not exact figures.
CVR 360607945% to under 10% of capital and votesnotified 26 Dec 202510 Mar 2020 to 23 Dec 2025
CVR 3606082415% to under 20% of capital and votesnotified 10 Aug 20207 May 2019 to 21 Sep 2021
CVR records founders at incorporation. It does not record whether they are alive or still involved.
| Metric | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Gross profit | -143 | -103 | -104 | 187 | 68 |
| Operating profit | -143 | -103 | -104 | +187 | +68 |
| Result for the year | -123 | -92 | -94 | +176 | +58 |
| Equity | -336 | -428 | -522 | -346 | -288 |
| Total assets | 44 | 48 | 50 | 46 | 5 |
| Employees (average) | Not reported | Not reported | Not reported | Not reported | 0 |
| Credit metrics (Dandex calculations) | |||||
| Gross profit growth (vækst i bruttofortjeneste) | n.m.note 1 | n.m.note 1 | n.m.note 1 | n.m.note 1 | -63.7% |
| EBITDA | -143 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 | Not reportednote 2 |
| Net interest-bearing debt (NIBD, nettorentebærende gæld) | -8note 3 | -15note 3 | -19note 3 | -39note 3 | -2note 3 |
DKK thousands. Annual reports via XBRL. Employees are the annual report's average and may cover a group.
Credit metrics are Dandex calculations from the filed figures, not filed values; estimates are in grey with a note. Ratios are percentages and gearing a multiple. Definitions. Revenue-based rows are empty: the company reports gross profit only (bruttofortjeneste), which class B filers may. No cash flow statement filed (class A and B are exempt).
Annual report 2025
1 Jan 2025 to 31 Dec 2025, published 18 Jun 2026
Annual report 2024
1 Jan 2024 to 31 Dec 2024, published 29 Jun 2025
Annual report 2023
1 Jan 2023 to 31 Dec 2023, published 6 Jun 2024
Annual report 2022
1 Jan 2022 to 31 Dec 2022, published 15 Jun 2023
Annual report 2021
1 Jan 2021 to 31 Dec 2021, published 18 May 2022
Each registered value from the day it took effect, newest first.
From CVR, read 4 Nov 2026. Text such as the signing rule and purpose is shown as registered.
2 registrations, newest first. As published by Erhvervsstyrelsen, in Danish, with people's street addresses cut to postcode and city.
Ny adresse: c/o Symbion, Fruebjergvej 3, 2100 København Ø
Stiftelsesdato: 07.05.2019.
Virkningsdato: 07.05.2019.
Seneste vedtægtsdato: 07.05.2019.
Kapital:
kr. 40.000,00.
Kapitalklasser: Nej
Indbetalingsmåde: Indbetalt kontant kr. 40.000,00 til kurs 100,00, fuldt indbetalt.
Stifter:
CVR-NR. 36060824 BKG INVESTERING 2014 ApS, c/o Mikkel Bender, Øster Farimagsgade 37, 2100 København Ø, den 07.05.2019.
Direktion:
Mikkel Bender, den 07.05.2019.
Selskabet tegnes af den samlede direktion eller af en direktør..
Første regnskabsår:
07.05.2019 - 31.12.2019.
Regnskabsår:
01.01 - 31.12.
Formål:
Selskabets formål er at forske i og udvikle biomedicinske stoffer til behandling af infektionersamt at udføre dertil relateret rådgivning.
1 registered in CVR.
P-number 1024685337Fruebjergvej 3, 2100 København Ø
